Abiopharma

🔍 Zhang Ximeng Simon (Executive)

Company: MERCURY GENERAL CORP (MCY)

Report Date: 2026-02-21

Detailed Transactions and Holdings:

• Acquired 1,388 shares of Restricted Stock Unit (Derivative)
  Date: 2026-02-21 | Code: A | equity_swap_involved: false | shares_owned_after: 1,388.30 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Each restricted stock unit is the economic equivalent of one share of the Issuer's Common Stock. The restricted stock units will vest in three equal annual installments beginning on February 21, 2027, and will be settled in cash upon vesting.
• REMARKS: VP and Chief Data & Analytics Officer